SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation for Cambridge biotech SolasCure's ...

Diabetic foot ulcers (DFUs) are a major clinical challenge, with high rates of morbidity, disability, amputations and ...

Dr. Chandan Sen, director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh, calls diabetic foot ulcers "invisible wounds." Sen is also a professor in the Department ...

Researchers identified a biomarker that may predict the recurrence of a diabetic foot ulcer that had previously healed. In a study published in Diabetes Care, researchers measured transepidermal water ...

Phoenix-Aid, an Oshkosh firm, won the 2025 Wisconsin Governor’s Business Plan Contest for its nano-composite wound dressing.

If there’s one thing I’ve learned through discussing wound care with my patients over the years, it’s that some of the greatest obstacles are not medical, but myths.

Compromised restoration of the skin barrier function of closed DFUs, as measured by high TEWL, is associated with increased odds of recurrence.

The rainy season brings added risks for people with foot ulcers, but with timely recognition of warning signs and proper care ...

Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, ...